M

Mammoth Biosciences

180 employees

Mammoth Biosciences develops novel CRISPR applications for disease detection, research, agriculture, biodefense, and more.

Basic info

Industry

biotechnology research

Sectors

Health Diagnostics
Biotechnology
Genetics
Life Science

Date founded

2017

Funding rounds raised

Total raised

$150M

from 32 investors over 32 rounds

M

Mammoth Biosciences raised $150M on September 9, 2021

Investors: Greenspring Associates, Foresite Capital, Decheng Capital, Redmile Group, Plum Alley Investments, Mayfield Fund, Senator Investment Group LP and Sixth Street

M

Mammoth Biosciences raised $45M on November 4, 2020

Investors: Foresite Capital, Redmile Group, Amazon.com, Sixth Street, Mayfield Fund and Decheng Capital

M

Mammoth Biosciences raised undisclosed on July 31, 2020

Investors: National Institutes of Health

M

Mammoth Biosciences raised $45M on January 30, 2020

Investors: Decheng Capital, Verily, Pacific 8 Ventures, Mayfield Fund, Plum Alley Investments and aMoon Fund

M

Mammoth Biosciences raised $23M on July 31, 2018

Investors: Tectonic Capital, DHVC, Mayfield Fund, Plum Alley Investments, 8VC and SV Angel

M

Mammoth Biosciences raised $1.4M on November 22, 2017

Investors: K50 Ventures

M

Mammoth Biosciences raised $120K on May 31, 2017

Investors: AME Cloud Ventures, Mayfield Fund, Wireframe Ventures and 8VC

FAQ